HDII Stock Overview

Designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. More details

HDII fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($284)

Latest financial reports are more than a year old

My Notes

Capture your thoughts, links and company narrative

Hypertension Diagnostics, Inc. Competitors

Motus GI Holdings

OTCPK:MOTS

US$1.4k

ThermoGenesis Holdings

OTCPK:THMO

US$4.8k

BIMI Holdings

OTCPK:BIMI

US$1.4k

UpHealth

OTCPK:UPHL

US$3.8k

Price History & Performance

Summary of share price highs, lows and changes for Hypertension Diagnostics
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0002
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	n/a
3 Year Change	-99.99%
5 Year Change	-99.98%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	HDII	US Medical Equipment	US Market
7D	0%	0.4%	1.2%
1Y	n/a	13.3%	21.0%

Return vs Industry: Insufficient data to determine how HDII performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how HDII performed against the US Market.

Price Volatility

Is HDII's price volatile compared to industry and market?
HDII volatility
HDII Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.1%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: HDII's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine HDII's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1988	n/a	Liangjian Peng	www.hypertensiondiagnostics.com

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient’s arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas.

Hypertension Diagnostics, Inc. Fundamentals Summary

How do Hypertension Diagnostics's earnings and revenue compare to its market cap?
HDII fundamental statistics
Market cap	US$284.00
Earnings (TTM)	-US$125.39k
Revenue (TTM)	US$3.79m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is HDII overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HDII income statement (TTM)
Revenue	US$3.79m
Cost of Revenue	US$2.84m
Gross Profit	US$954.47k
Other Expenses	US$1.08m
Earnings	-US$125.39k

Last Reported Earnings

Dec 31, 2018

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did HDII perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/11 06:57
End of Day Share Price	2025/02/07 00:00
Earnings	2018/12/31
Annual Earnings	2018/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hypertension Diagnostics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.